Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly-Preliminary results of the GIM-13 AMBRA study.

被引：0
|
作者：
Mustacchi, Giorgio
Pronzato, Paolo
D'Alonzo, Alessia
Mocerino, Carmela
Romagnoli, Emanuela
Garrone, Ornella
Blasi, Livio
De Laurentiis, Michelino
Michelotti, Andrea
Bologna, Alessandra
Giordano, Monica
Turletti, Anna
Montemurro, Filippo
De Placido, Sabino
Natoli, Clara
Taverniti, Cristiana
Biganzoli, Laura
Meattini, Icro
Marchetti, Paolo
Cazzaniga, Marina Elena
机构：
[1] Univ Trieste, Trieste, Italy
[2] San Martino IST Ist Naz Ric Cancr, Genoa, Italy
[3] Osped Policlin San Martino Oncol Med, Genoa, Italy
[4] AORN A Cardarelli Hosp, Naples, Italy
[5] Osped Macerata, UOC Oncol, Macerata, Italy
[6] S Croce & Carle Teaching Hosp, Med Oncol, Cuneo, Italy
[7] Fdn San Raffaele Giglio, Palerio, Italy
[8] Fdn Pascale, Breast Unit, Naples, Italy
[9] Azienda Osped Univ Pisana, Oncol Unit 1, Pisa, Italy
[10] IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[11] Santa Anna Hosp, Como, Italy
[12] ASLTO1 Osped Martini, Med Oncol, Turin, Italy
[13] Invest Clin Oncol Candiolo Canc Inst FPO IRCCS, Candiolo, Italy
[14] Univ Naples Federico II, Naples, Italy
[15] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy
[16] AOU Citta Salute & Sci, Med Oncol, Turin, Italy
[17] Hosp Prato, Sandro Pitigliani Med Oncol Dept, Prato, Italy
[18] Univ Florence, Florence, Italy
[19] Sapienza Univ Rome, S Andrea Hosp, Rome, Italy
[20] Hosp San Gerardo, Oncol Unit, Monza, MB, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NAB-PACLITAXEL (NAB-P) IN HER2-VE ADVANCED BREAST CANCER (ABC) PATIENTS (PTS): FOCUS ON LUMINAL CANCERS. RESULTS FROM GIM13-AMBRA STUDY
    Cazzaniga, Marina Elena
    Mustacchi, Giorgio
    Bria, Emilio
    Bisagni, Giancarlo
    Biganzoli, Laura
    Pronzato, Paolo
    De Placido, Sabino
    Romagnoli, Emanuela
    Montemurro, Filippo
    Marchetti, Paolo
    De laurentis, Michelino
    Riccardi, Ferdinando
    Turletti, Anna
    Michelotti, Andrea
    Natoli, Clara
    Livi, Lorenzo
    Del Mastro, Lucia
    Donadio, Michela
    Garrone, Ornella
    Giordano, Monica
    BREAST, 2017, 36 : S51 - S52
  • [2] 2Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): focus on luminal cancers. Results from GIM13-AMBRA study
    Mustacchi, G.
    Cazzaniga, M.
    Giordano, M.
    Garrone, O.
    Donadio, M.
    Del Mastro, L.
    Livi, L.
    Natoli, C.
    Michelotti, A.
    Turletti, A.
    Riccardi, F.
    Marchetti, P.
    Montemurro, F.
    Romagnoli, E.
    De Placido, S.
    Biganzoli, L.
    Bisagni, G.
    Bria, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): From randomized trials to real-life setting: Results from GIM13-AMBRA study
    Mustacchi, G.
    Cazzaniga, M.
    Bria, E.
    Bisagni, G.
    Biganzoli, L.
    Pronzato, P.
    De Placido, S.
    Romagnoli, E.
    Montemurro, F.
    Marchetti, P.
    De laurentiis, M.
    Riccardi, F.
    Turletti, A.
    Michelotti, A.
    Natoli, C.
    Livi, L.
    Del Mastro, L.
    Donadio, M.
    Garrone, O.
    Giordano, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] First-line therapy with fulvestrant (FUL) in HR+ve, HER2-ve advanced pre-treated breast cancer (ABC) patients (pts): Results from the GIM-13 AMBRA Study.
    Pronzato, Paolo
    Mustacchi, Giorgio
    Giordano, Monica
    Garrone, Ornella
    Del Mastro, Lucia
    Natoli, Clara
    Turletti, Anna
    Romagnoli, Emanuela
    Bologna, Alessandra
    Mocerino, Carmela
    Alu, Massimiliano
    De Angelis, Claudia
    Aversa, Caterina
    Arpino, Grazia
    Taverniti, Cristiana
    Biganzoli, Laura
    Meattini, Icro
    Piezzo, Michela
    Cazzaniga, Marina Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Choices of first-line therapy in her2-ve advanced breast cancer (abc) patients (pts). prelimary results of the gim-13-ambra study
    Cazzaniga, M. E.
    Mustacchi, G.
    Giordano, M.
    Garrone, O.
    Donadio, M.
    Del Mastro, L.
    Livi, L.
    Natoli, C.
    Michelotti, A.
    Turletti, A.
    Riccardi, F.
    Paolo, P.
    De Placido, S.
    De laurentiis, M.
    Marchetti, P.
    Montemurro, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Expression of SPARC and response to nab-paclitaxel (nab-p) in patients (pts) with metastatic breast cancer (MBC)
    Schneeweiss, Andreas
    Aigner, Julia
    Smetanay, Katherina
    Schuetz, Florian
    Sohn, Christof
    Kriegsmann, Mark
    Jaeger, Dirk
    Zorn, Markus
    Bachinger, Andreas
    Sinn, Hans-Peter
    Marme, Frederik
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Nab-paclitaxel (nab-P) combined with FOLFOX for advanced pancreatic cancer: A phase I study.
    Safran, Howard
    Perez, Kimberly
    Charpentier, Kevin
    Austin, Trevor Clark
    Mantripragada, Kalyan C.
    Bishop, Kenneth D.
    Lombardo, Alise
    Houlihan, Lindsay
    Mitchell, Kristen
    Rosati, Kayla
    Martel, Diane
    Shaw, Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents: Results from the GIM-13 AMBRA study.
    Cazzaniga, Marina Elena
    Pronzato, Paolo
    Schettini, Francesco
    Del Mastro, Lucia
    Riemma, Maria
    Alu, Massimiliano
    Turletti, Anna
    Giordano, Monica
    Pugliese, Palma
    De Angelis, Claudia
    Garrone, Ornella
    Marchetti, Paolo
    Riccardi, Ferdinando
    Bernardo, Antonio
    Livi, Lorenzo
    Fabi, Alessandra
    Taverniti, Cristiana
    De Placido, Sabino
    Mustacchi, Giorgio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Nab-paclitaxel (nab-P) in metastatic breast cancer (MBC) in elderly patients: A real life setting (NEREIDE study)
    Adamo, V.
    Ricciardi, G. R. R.
    Schifano, S.
    Russo, A.
    Gebbia, V.
    Blasi, L.
    Giuffrida, D.
    Scandurra, G.
    Savarino, A.
    Butera, A.
    Borsellino, N.
    Verderame, F.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2018, 29
12345